- Report
- May 2022
- 47 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Dienogest is a synthetic progestin used in the treatment of endometriosis and other gynecological disorders. It is a member of the 19-nortestosterone family of progestins and is used in combination with estrogens in oral contraceptives. Dienogest is also used in the treatment of heavy menstrual bleeding and as a hormone replacement therapy for menopausal symptoms.
Dienogest is a key player in the Sexual and Reproductive Health Drugs market, providing a safe and effective treatment for a range of gynecological disorders. It is used in combination with estrogens in oral contraceptives, providing a reliable form of contraception. It is also used in the treatment of heavy menstrual bleeding and as a hormone replacement therapy for menopausal symptoms.
Companies in the Dienogest market include Bayer AG, Merck KGaA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Mylan N.V. Show Less Read more